Skip to content
TTM Q1 '26TTM Q4 '25TTM Q3 '25TTM Q2 '25TTM Q1 '25
-$9.67M-44.2%-$9.16M-56.3%-$8.34M-62.8%-$7.71M-93.3%-$6.71M-139%
$291.61K+6.0%$287.96K+7.7%$281.93K+8.9%$279.2K+16.5%$275.09K
$2.17M+67.1%$1.99M+76.6%$1.63M+77.8%$1.52M$1.3M
-$6.89M+30.5%-$6.5M+23.6%-$10.24M-186%-$8.92M-$9.92M
$196.48K-29.5%$169.92K-57.1%$305.34K+3.2%$292.03K$278.69K
-$176.78K+36.6%-$150.22K+61.5%-$285.64K+1.3%-$272.33K-$278.69K
$18.57M
-$7.07M-184%-$6.68M-169%$4.86M+2,122%$6.83M$8.4M
-$7.09M+30.5%-$6.67M+25.1%-$10.54M-172%-$9.21M-$10.2M

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

How much cash does eXoZymes Inc. Common Stock generate?
eXoZymes Inc. Common Stock (EXOZ) generated -$6.9M in operating cash flow over the trailing twelve months.
What is eXoZymes Inc. Common Stock's free cash flow?
After $196.5K of capital expenditures, eXoZymes Inc. Common Stock's free cash flow was -$7.1M over the trailing twelve months, up 30.5% year over year.
Where does eXoZymes Inc. Common Stock's cash flow data come from?
Every line is extracted from eXoZymes Inc. Common Stock's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.